519 related articles for article (PubMed ID: 7890059)
21. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
[TBL] [Abstract][Full Text] [Related]
22. Direct effects of progesterone and antiprogesterone on human sperm hyperactivated motility and acrosome reaction.
Uhler ML; Leung A; Chan SY; Wang C
Fertil Steril; 1992 Dec; 58(6):1191-8. PubMed ID: 1459270
[TBL] [Abstract][Full Text] [Related]
23. Mode of action of RU 486.
Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
[TBL] [Abstract][Full Text] [Related]
24. Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.
Murphy AA; Morales AJ; Kettel LM; Yen SS
Fertil Steril; 1995 Jul; 64(1):187-90. PubMed ID: 7789557
[TBL] [Abstract][Full Text] [Related]
25. Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists.
Slayden OD; Brenner RM
Arch Histol Cytol; 2004 Dec; 67(5):393-409. PubMed ID: 15781981
[TBL] [Abstract][Full Text] [Related]
26. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Nayak NR; Sengupta J; Ghosh D
Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
[TBL] [Abstract][Full Text] [Related]
27. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
28. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
Slayden OD; Nayak NR; Burton KA; Chwalisz K; Cameron ST; Critchley HO; Baird DT; Brenner RM
J Clin Endocrinol Metab; 2001 Jun; 86(6):2668-79. PubMed ID: 11397870
[TBL] [Abstract][Full Text] [Related]
29. Effects of daily low dose mifepristone on endometrial maturation and proliferation.
Cameron ST; Critchley HO; Thong KJ; Buckley CH; Williams AR; Baird DT
Hum Reprod; 1996 Nov; 11(11):2518-26. PubMed ID: 8981147
[TBL] [Abstract][Full Text] [Related]
30. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
[TBL] [Abstract][Full Text] [Related]
31. The effects of progesterone receptor blockade in the luteal phase of normal fertile women.
Li TC; Dockery P; Thomas P; Rogers AW; Lenton EA; Cooke ID
Fertil Steril; 1988 Nov; 50(5):732-42. PubMed ID: 3181485
[TBL] [Abstract][Full Text] [Related]
32. Human endometrial epithelial telomerase is important for epithelial proliferation and glandular formation with potential implications in endometriosis.
Valentijn AJ; Saretzki G; Tempest N; Critchley HO; Hapangama DK
Hum Reprod; 2015 Dec; 30(12):2816-28. PubMed ID: 26498179
[TBL] [Abstract][Full Text] [Related]
33. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
Mäentausta O; Svalander P; Danielsson KG; Bygdeman M; Vihko R
J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465
[TBL] [Abstract][Full Text] [Related]
34. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
Swahn ML; Bygdeman M; Seppälä M; Johannisson E; Cekan S
Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
[TBL] [Abstract][Full Text] [Related]
35. The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase.
Dockery P; Ismail RM; Li TC; Warren MA; Cooke ID
Hum Reprod; 1997 Aug; 12(8):1778-84. PubMed ID: 9308811
[TBL] [Abstract][Full Text] [Related]
36. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
37. Mifepristone: a potential contraceptive.
Heikinheimo O; Archer DF
Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels.
Perrot-Applanat M; Deng M; Fernandez H; Lelaidier C; Meduri G; Bouchard P
J Clin Endocrinol Metab; 1994 Jan; 78(1):216-24. PubMed ID: 8288707
[TBL] [Abstract][Full Text] [Related]
39. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
40. RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta).
Slayden OD; Brenner RM
J Clin Endocrinol Metab; 1994 Feb; 78(2):440-8. PubMed ID: 8106633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
